Clinical Trials on Moderated Cholesterolemia in France

Total 73 results

Multimed

Completed

Study of the Effects of a Mineralized Water Ingestion Upon Lipidic Absorption Mechanisms

Moderated Cholesterolemia

France
Centre Hospitalier Universitaire Dijon

Recruiting

Effects of Eccentric Pedaling at Different Rates on Neuromuscular Function (Exo-Mode 3)

Volunteers Who Can do Moderate Physical Activity

France
Nantes University Hospital

Completed

Gait Analysis in Moderate Hemophiliac Patients (AQM-Hemophile)

Arthropathy | Moderate Hemophilia

France
MedDay Pharmaceuticals SA
Eurofins Optimed

Terminated

HI Study to Assess and Compare the Pharmacokinetic Parameters of MD1003 in Hepatic Impaired Patients and Healthy Subjects

Healthy Volunteers | Hepatic Impairment of Moderate Child Pugh Category

France, Hungary
Ipsen

Completed

Efficacy and Safety of Clostridium Botulinum Toxin Type A to Improve Appearance of Moderate to Severe Glabellar Lines (BTX-A-HAC NG)

Moderate to Severe Glabellar Lines

France, Germany
University Hospital, Montpellier

Completed

Alveolar Bone Graft Cortical Nasal Floor

Alveolar Cleft Operated on an Alveolar Bone Graft

France
AB Biotics, SA

Completed

A Trial to Evaluate the Efficacy of AB-Life Probiotic Product on LDL-Cholesterol Reduction in Moderate Hypercholesterolemia

Moderate Hypercholesterolemia

France
PiLeJe

Completed

Management Strategy for Mild to Moderate Major Depression: Combination of Rhodiola and Saffron Extracts.

Mild to Moderate Depression

France
Assistance Publique - Hôpitaux de Paris
URC-CIC Paris Descartes Necker Cochin

Recruiting

Nitrous Oxide for Analgesia During Nasogastric Tube Placement in Young Children (SONGER)

Mild to Moderate Dehydration

France
University Hospital, Toulouse

Recruiting

Paramedical Tele-education on Moderate Depressive Episodes (TE-DSP)

Depression | Depression Moderate

France
Kythera Biopharmaceuticals
Bayer

Completed

Evaluation of Safety and Efficacy of Deoxycholic Acid Injection (ATX-101) in the Reduction of Submental Fat

Moderate or Severe Submental Fullness

Belgium, France, Germany, Italy, Spain, United Kingdom
Kythera Biopharmaceuticals
Bayer

Completed

Evaluation of Safety and Efficacy of Deoxycholic Acid Injection (ATX-101) in the Reduction of Submental Fat

Moderate or Severe Submental Fullness

Germany, France, Belgium, Spain, United Kingdom
Assistance Publique Hopitaux De Marseille

Completed

Feasibility and Acceptability of an Educational Intervention to Improve the Management of Depression in Primary Care.

Patients With Moderate Depression, | First or Second Episode

France
Assistance Publique - Hôpitaux de Paris

Completed

Ulna Length in Black Children (ULNOIR)

Ulna Length in Otherwise Healthy Children (With the Exception of Mild to Moderate Asthma)

France
Novartis

Completed

Efficacy and Tolerability of an Aliskiren-based Treatment Algorithm in Patients With Mild to Moderate Hypertension

Essential Hypertension ( Mild to Moderate)

Romania, Slovakia, Hungary, France
Ipsen

Recruiting

A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Moderate to Severe Upper Facial Lines (LANTIC)

Moderate to Severe Upper Facial Lines

Germany, France
University of California, Irvine

Recruiting

Acupuncture Therapy and Hypertension

Mild to Moderate Hypertension

United States
Pfizer

Terminated

Safety and Pharmacokinetic Study of EMBEDA in Children Ages 7-17 With Pain

Moderate-severe Pain

United States
Decathlon SE
EFOR, France

Recruiting

Assessment of the Safety and Performance of Knee Ligament Supports in the Context of a Return to Sport After Sprain

Anterior Cruciate Ligament Tear | Knee Sprain (Mild) | Knee Sprain (Moderate)

France
Santen SAS

Completed

Double-Masked Trial of NOVA22007 (Ciclosporin 0.1%) Versus Vehicle in Patients With Moderate to Severe Dry Eye Syndrome

Moderate to Severe Dry Eye Syndrome

France
University Hospital, Angers
Biomathics

Unknown

Gait, cOgnitiOn & Decline (GOOD)

Healthy | Mild Cognitive Impairment | Mild Dementia | Moderate Dementia

France
Assistance Publique - Hôpitaux de Paris

Recruiting

Levosimendan Versus Placebo Before Tricuspid Valve Surgery in Patients With Right Ventricular Dysfunction (LEONARD)

Patients Referred for an Isolated or a Combined Surgical Correction of Functional Moderate to Severe Tricuspid

France
Otsuka Pharmaceutical Europe Ltd

Completed

Adacolumn in Refractory UC Patients Trial (ART)

Ulcerative Colitis, Active Moderate

France
Centre Antoine Lacassagne

Recruiting

Study to Determine the Safety and Efficacy of Ribociclib in Combination With Hormone Therapy and Hypofractionated Radiotherapy in Breast Cancer, With Positive Hormone Receptors and Negative HER2 Status, in Newly Diagnosed, Not Immediately Operable Elderly Patient (CALHYS) (CALHYS)

HER2 Negative Breast Cancer Not Immediately Operated

France
Poitiers University Hospital

Recruiting

Early High-flow Oxygen Therapy With nebuLized Beta-2-agonist Using a Vibrating Mesh for the Management of Moderate to Severe Asthma Exacerbation in the Emergency Department (EOLE)

Moderate Asthma Exacerbation | Severe Asthma Exacerbation

France
Hospices Civils de Lyon

Completed

Ante-hypophyseal Dysfunctions in Children Following Moderate to Severe Traumatic Brain Injuries (Endoc-TC)

Moderate to Severe Traumatic Brain Injury

France
Assistance Publique - Hôpitaux de Paris

Recruiting

Cognitive Rehabilitation of Working Memory After Moderate to Severe Traumatic Brain Injury (REHAB-MDT)

Moderate to Severe Traumatic Brain Injury

France
Centre Hospitalier Universitaire de Nice

Completed

Evaluation of Efficacy and Patient Acceptance of Sound Amplifier Téo First, in Mild and Moderate Presbycusis Patient 60 Years of Age and Older, With no Previous Hearing Aid (TEO FIRST)

- Mild and Moderate Presbycusis (20 to 50 dB Average Hearing Loss at 500, 1000, 2000 Hz and 4000 Hz)

France
Assistance Publique - Hôpitaux de Paris
The Paul Bennetot Foundation

Completed

Pilot Study of a Robot-assisted Intervention for the Management of Care-induced Pain in Dementia (PARODOL)

Moderate to Severe Dementia

France
Institut de Sante Publique, d'Epidemiologie et...

Completed

Effectiveness of Care Management in Alzheimer Patients (AIDALZ)

Alzheimer Disease or Associated Disorder | Mild to Moderately Severe Dementia

France
University Hospital, Montpellier

Completed

SvO2 Trigger in Transfusion Strategy After Cardiac Surgery (ReTSEACS)

Undergoing Nonemergent Cardiac Surgery | Central Venous Catheter on the Superior Vena Cava (to Perform ScVO2 Measure) | Anemia (<9g/dL) Requiring Blood Transfusion | Hemodynamic and Respiratory Stability | Bleeding Graded as Insignificant, Mild, Moderate of Universal Definition of Perioperative...

France
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Upper Airway Reeducation in Moderate Obstructive Sleep Apnea Syndrome (SAOSGENIO)

Moderate Obstructive Sleep Apnea Syndrome

France
Nantes University Hospital

Completed

Continuous Hyperosomolar Therapy for Traumatic Brain-injured Patients (COBI)

Moderate to Severe Traumatic Brain Injury

France
Mallinckrodt

Completed

A Study of Fibrocaps™ in Surgical Bleeding (FINISH-3)

Mild or Moderate Surgical Bleeding

United States, Netherlands, United Kingdom, Belgium
AbGenomics B.V Taiwan Branch

Completed

Phase IIa Study of Multiple Doses of AbGn-168H by iv Infusion in Moderate to Severe Chronic Plaque Psoriasis Patients (AbGn-168H)

Moderate to Severe Chronic Plaque Psoriasis

United States
Novartis Pharmaceuticals

Completed

First Study of Secukinumab in Pre-filled Syringes in Subjects With Chronic Plaque-type Psoriasis: Response at 12 Weeks (FEATURE)

Moderate to Severe Plaque-type Psoriasis

Germany, United States, Estonia, France, Canada
Assistance Publique Hopitaux De Marseille

Not yet recruiting

Effects on Biotrauma of NMBAs and PP Association During ARDS (CURA-PRONE)

Moderate to Severe Acute Respiratory Distress Syndrome

France
Kristian Reich, MD
LEO Pharma

Completed

Optimising Outpatient Care in Mild to Moderate Psoriasis (PSO-TOP) (PSO-TOP)

Mild to Moderate Psoriasis

United Kingdom, Germany, France, Spain, Netherlands, Sweden, Italy, Denmark
AbGenomics B.V Taiwan Branch

Completed

A Study of Multiple Doses of AbGn-168H by Intravenous Infusion in Patients With Moderate to Severe Chronic Plaque Psoriasis

Moderate to Severe Chronic Plaque Psoriasis

United States
Hospices Civils de Lyon

Unknown

Measurement of the Efficacy of MORPHINE in the Early Management of Dyspnea in COVID-19 Positive Patients (CODYS)

COVID-19 Disease | Patients Hospitalized in the Hospices Civils of Lyon | Moderate to Severe Dyspnea | Without Resuscitation Objective Management

France
Assistance Publique - Hôpitaux de Paris
Gustave Roussy, Cancer Campus, Grand Paris

Not yet recruiting

Calprotectin, a Biomarker of COVID-19 Severity (CALPRO) (CALPRO)

Myelodysplastic Syndromes | Chronic Myelomonocytic Leukemia | Old Age | Severe/Moderate Coronavirus

France
Centre Hospitalier Saint Joseph Saint Luc de Lyon

Not yet recruiting

Assessment of the Effect of Restriction on Alimentary AGE in Progression of Chronic Kidney Disease (CKD AGE)

Kidney Failure, Chronic | Diet Habit | Chronic Kidney Disease stage3 | Chronic Kidney Disease Stage 3B | Chronic Kidney Disease, Stage 3 (Moderate) | Chronic Kidney Disease Stage 3A (Disorder)

France
Helius Medical Inc
Kessler Institute for Rehabilitation

Unknown

PoNS Clinical Experience Program (TBI)

Mild to Moderate Traumatic Brain Injury

United States
Assistance Publique - Hôpitaux de Paris
Ministry of Health, France; National Cancer Institute, France; Université de...

Recruiting

Molecular Signature From Tumor to Lymph Nodes (N2-3S)

Lung Cancer | Stage IIIA-cN2 | Operated With Curative Intent | Primary Tumor Tissue Available | Node Tumor Tissue Available

France
AbbVie (prior sponsor, Abbott)

Completed

Open Label Continuation Study in Moderate to Severe Psoriasis

Moderate to Severe Plaque Psoriasis

United States, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Greece, Italy, Spain, Sweden, Switzerland, United Kingdom
Bausch Health Americas, Inc.

Terminated

P3 Study Brodalumab in Treatment of Moderate to Severe Plaque Psoriasis (AMAGINE-2)

Moderate to Severe Plaque Psoriasis

United States, Austria, France, Poland, Australia, Czechia, Canada, Hungary, Portugal, Spain, Netherlands
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Subcutaneous Secukinumab (AIN457) for Moderate to Severe Chronic Plaque-type Psoriasis Assessing Different Doses and Dose Regimens (SCULPTURE)

Moderate to Severe Plaque-type Psoriasis

United States, Czech Republic, Austria, Germany, India, Japan, Bulgaria, Singapore, Switzerland, United Kingdom, Italy, France, Poland, Slovakia, Canada, Vietnam
Novartis Pharmaceuticals

Completed

Extension Study of Secukinumab Prefilled Syringes in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis Completing Preceding Psoriasis Phase III Studies With Secukinumab

Moderate to Severe Plaque-type Psoriasis

Germany, United States, Belgium, Colombia, Spain, Estonia, Hungary, Japan, Lithuania, Taiwan, Australia, Korea, Republic of, Canada, Singapore, Italy, Israel, Sweden, Guatemala, United Kingdom, Argentina, France, Poland, Latvia, Iceland, Finla... and more
Fresenius Kabi SwissBioSim GmbH
Merck KGaA, Darmstadt, Germany

Completed

MSB11022 in Moderate to Severe Chronic Plaque Psoriasis (AURIEL-PsO)

Psoriasis | Moderate to Severe Plaque Psoriasis | Plaque Type Psoriasis

United States, Canada, Czechia, Hungary, Russian Federation, Bulgaria, Mexico, United Kingdom, Poland, Germany, Estonia, France
Bayer

Completed

A Study to Assess the Efficacy and Safety of Enteric-Coated Acetylsalicylic Acid in Patients at Moderate Risk of Cardiovascular Disease (ARRIVE)

Moderate Risk of CVD

Poland, United States, Italy, United Kingdom, Germany, Spain, Puerto Rico, Ireland

Clinical Trials on Moderated Cholesterolemia in France

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in El Salvador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations